Gynecologic cancers in pregnancy: Guidelines of an international consensus meeting

International Journal of Gynecological Cancer

Volumn 19, Issue SUPPL. 1, 2009, Pages

  Amant, Frédéric ^a   Van Calsteren, Kristel ^a   Halaska, Michael J ^b   Beijnen, Jos ^c   Lagae, Lieven ^d   Hanssens, Myriam ^a   Heyns, Liesbeth ^a   Lannoo, Lore ^a   Ottevanger, Nelleke P ^e   Bogaert, Walter Vanden ^a   Ungar, Laszlo ^f   Vergote, Ignace ^a   Du Bois, Andreas ^g  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b CHARLES UNIVERSITY   (Czech Republic)

^c SLOTERVAART HOSPITAL   (Netherlands)

^d Nijmegen Medical Centre ^*

^e RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^f Department of Gastroenterology and Endoscopy   (Hungary)

^g HSK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC METAL COMPLEX; ATOSIBAN; BETAMETHASONE; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DEXAMETHASONE; DOCETAXEL; DOXORUBICIN; ERYTHROPOIETIN; ETOPOSIDE; GENTAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; HYDROCORTISONE; INDOMETACIN; METHYLPREDNISOLONE; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PACLITAXEL; PARACETAMOL; TECHNETIUM 99M; UNINDEXED DRUG; UTERUS SPASMOLYTIC AGENT; VINBLASTINE; VINCA ALKALOID;

ADJUVANT CHEMOTHERAPY; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER THERAPY; CESAREAN SECTION; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONGENITAL MALFORMATION; CONSENSUS; COUNSELING; DELIVERY; ECHOGRAPHY; ETHICS; FETUS DISEASE; FETUS RISK; GERM CELL TUMOR; GESTATIONAL AGE; GYNECOLOGIC CANCER; HEARING LOSS; HEART VENTRICLE HYPERTROPHY; HUMAN; HYDROCEPHALUS; IMAGING; LUNG CANCER; MATERNAL DISEASE; MEDICAL RESEARCH; METHODOLOGY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OUTCOME ASSESSMENT; OVARY CANCER; PARENT; PELVIS SURGERY; PERSONAL EXPERIENCE; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RADIATION DOSE; SENTINEL LYMPH NODE BIOPSY; SEPSIS; SIDE EFFECT; SOCIAL PSYCHOLOGY; STANDARD; THIRD TRIMESTER PREGNANCY; TUMOR BIOPSY; UTERINE CERVIX CANCER; VENTRICULOMEGALY; VULVA CANCER; ALGORITHM; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; FEMALE; FEMALE GENITAL TRACT TUMOR; GYNECOLOGIC SURGERY; INTERNATIONAL COOPERATION; MULTICENTER STUDY; PATHOLOGY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PRENATAL EXPOSURE;

ALGORITHMS; FEMALE; GENITAL NEOPLASMS, FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; INTERNATIONAL COOPERATION; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 69949166303     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181a1d0ec     Document Type: Conference Paper

References (158)

1. Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol. 2006;20:207-225.
2. Gustafsson L, Ponten J, Zack M, et al. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control. 1997;8:755-763.
3. Pavlidis NA. Coexistence of pregnancy and malignancy. Oncologist. 2002;7:279-287.
4. Bernhard LM, Klebba PK, Gray DL, et al. Predictors of persistence of adnexal masses in pregnancy. Obstet Gynecol. 1999;93:585-589.
5. Giuntoli RL, Vang RS, Bristow RE. Evaluation and management of adnexal masses during pregnancy. Clin Obstet Gynecol. 2006;49:492-505.
6. Oehler MK, Wain GV, Brand A. Gynaecological malignancies in pregnancy: a review. Aust N Z J Obstet Gynaecol. 2003;43:414Y420.
7. Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004;5:283-291.
8. Kal HB, Struikmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol. 2005;6:328-333.
9. Nagayama M, Watanabe Y, Okumura A, et al. Fast MR imaging in obstetrics. Radiographics. 2002;22:563-580.
10. Reddy UM, Filly RA, Copel JA. Prenatal imaging: ultrasonography and magnetic resonance imaging. Obstet Gynecol. 2008;112:145-157.
11. Webb JA, Thomsen HS, Morcos SK. The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol. 2005;15:1234-1240.
12. Toppenberg KS, Hill DA, Miller DP. Safety of radiographic imaging during pregnancy. Am Fam Physician. 1999;59:1813-1818.
13. Brenner DJ, Hall EJ. Computed tomography- an increasing source of radiation exposure. N Engl J Med. 2007;357:2277-2284.
14. Doll R,Wakeford R. Risk of childhood cancer from fetal irradiation. Br J Radiol. 1997;70:130-139.
15. Lowe SA. Diagnostic radiography in pregnancy: risks and reality. Aust N Z J Obstet Gynaecol. 2004;44:191-196.
16. Zanotti-Fregonara P, Champion C, Trebossen R, et al. Estimation of the beta+ dose to the embryo resulting from 18F-FDG administration during early pregnancy. J Nucl Med. 2008;49:679-682.
17. Keleher A, Wendt R, III, Delpassand E, et al. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J. 2004;10:492-495.
18. Gentilini O, Cremonesi M, Trifiro G, et al. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol. 2004;15:1348-1351.
19. Pandit-Taskar N, Dauer LT, Montgomery L, et al. Organ and fetal absorbed dose estimates from 99mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients. J Nucl Med. 2006;47:1202-1208.
20. Van der Zee AG, Oonk MH, De Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26:884-889.
21. Albo D,Wayne JD, Hunt KK, et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg. 2001;182:393-398.
22. Crivellaro M, Senna G, Dama A, et al. Anaphylaxis due to patent blue dye during lymphography, with negative skin prick test. J Investig Allergol Clin Immunol. 2003;13:71-72.
23. Khera SY, Kiluk JV, Hasson DM, et al. Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping. Breast J. 2008;14:250-254.
24. Michael CW, Esfahani FM. Pregnancy-related changes: a retrospective review of 278 cervical smears. Diagn Cytopathol. 1997;17: 99-107.
25. Baldauf JJ, Dreyfus M, Ritter J, et al. Colposcopy and directed biopsy reliability during pregnancy: a cohort study. Eur J Obstet Gynecol Reprod Biol. 1995;62:31-36.
26. Douvier S, Filipuzzi L, Sagot P. Management of cervical intra-epithelial neoplasm during pregnancy. Gynecol Obstet Fertil. 2003;31: 851-855.
27. Van Calsteren K, Vergote I, Amant F. Cervical neoplasia during pregnancy: diagnosis, management and prognosis. Best Pract Res Clin Obstet Gynaecol. 2005;19:611-630.
28. Economos K, Perez VN, Delke I, et al. Abnormal cervical cytology in pregnancy: a 17-year experience. Obstet Gynecol. 1993;81: 915-918.
29. Vlahos G, Rodolakis A, Diakomanolis E, et al. Conservative management of cervical intraepithelial neoplasia (CIN(2-3)) in pregnant women. Gynecol Obstet Invest. 2002;54:78-81.
30. Palle C, Bangsboll S, Andreasson B. Cervical intraepithelial neoplasia in pregnancy. Acta Obstet Gynecol Scand. 2000;79:306-310.
31. Coppola A, Sorosky J, Casper R, et al. The clinical course of cervical carcinoma in situ diagnosed during pregnancy. Gynecol Oncol. 1997;67:162-165.
32. Yost NP, Santoso JT, McIntire DD, et al. Postpartum regression rates of antepartum cervical intraepithelial neoplasia II and III lesions. Obstet Gynecol. 1999;93:359-362.
33. Robova H, Rob L, Pluta M, et al. Squamous intraepithelial lesion-microinvasive carcinoma of the cervix during pregnancy. Eur J Gynaecol Oncol. 2005;26:611-614.
34. Ackermann S, Gehrsitz C, Mehlhorn G, et al. Management and course of histologically verified cervical carcinoma in situ during pregnancy. Acta Obstet Gynecol Scand. 2006;85:1134-1137.
35. Ni Mhuireachtaigh R, O'Gorman DA. Anesthesia in pregnant patients for nonobstetric surgery. J Clin Anesth. 2006;18:60-66.
36. Moran BJ, Yano H, Al Zahir N, et al. Conflicting priorities in surgical intervention for cancer in pregnancy. Lancet Oncol. 2007;8: 536-544.
37. Cohen-Kerem R, Railton C, Oren D, et al. Pregnancy outcome following non-obstetric surgical intervention. Am J Surg. 2005;190:467-473. (Pubitemid 41139305)
38. Giles W, Bisits A. Preterm labour. The present and future of tocolysis. Best Pract Res Clin Obstet Gynaecol. 2007;21:857-868.
39. Rizzo AG. Laparoscopic surgery in pregnancy: long-term follow-up. J Laparoendosc Adv Surg Tech A. 2003;13:11-15.
40. Mathevet P, Nessah K, Dargent D, et al. Laparoscopic management of adnexal masses in pregnancy: a case series. Eur J Obstet Gynecol Reprod Biol. 2003;108:217-222.
41. Yuen PM, Ng PS, Leung PL, et al. Outcome in laparoscopic management of persistent adnexal mass during the second trimester of pregnancy. Surg Endosc. 2004;18:1354-1357.
42. Jackson H, Granger S, Price R, et al. Diagnosis and laparoscopic treatment of surgical diseases during pregnancy: an evidence-based review. Surg Endosc. 2008;22:1917-1927.
43. Affleck DG, Handrahan DL, Egger MJ, et al. The laparoscopic management of appendicitis and cholelithiasis during pregnancy. Am J Surg. 1999;178:523-529.
44. Undevia SD, Gomez-Abuin G, Ratain MJ. Pharmacokinetic variability of anticancer agents. Nat Rev Cancer. 2005;5:447-458.
45. Krauer B, Krauer F, Hytten FE. Drug disposition and pharmacokinetics in the maternal-placental-fetal unit. Pharmacol Ther. 1980;10:301-328.
46. Van Calsteren K, Verbesselt R, Paridaens R, et al. Pregnancy induces decreased doxorubicin plasma levels and tissue toxicity. Abstract 14th International Meeting of the European Society of Gynaecological Oncology (ESGO). Berlin; 2007.
47. Syme MR, Paxton JW, Keelan JA. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet. 2004;43:487-514.
48. Bakri YN, Given FT Jr. Normal pregnancy and delivery following conservative surgery and chemotherapy for ovarian endodermal sinus tumor. Gynecol Oncol. 1984;19:222-225.
49. Caluwaerts S, Van Calsteren K, Mertens L, et al. Neoadjuvant chemotherapy followed by radical hysterectomy for invasive cervical cancer diagnosed during pregnancy: report of a case and review of the literature. Int J Gynecol Cancer. 2006;16:905-908.
50. Elit L, Bocking A, Kenyon C, et al. An endodermal sinus tumor diagnosed in pregnancy: case report and review of the literature. Gynecol Oncol. 1999;72:123-127.
51. Ferrandina G, Distefano M, Testa A, et al. Management of an advanced ovarian cancer at 15 weeks of gestation: case report and literature review. Gynecol Oncol. 2005;97:693-696.
52. Garrido M, Clavero J, Huete A, et al. Prolonged survival of a woman with lung cancer diagnosed and treated with chemotherapy during pregnancy. Review of cases reported. Lung Cancer. 2008;60:285-290.
53. Han JY, Nava-Ocampo AA, Kim TJ, et al. Pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for malignant ovarian germ cell tumors: report of 2 cases. Reprod Toxicol. 2005;19:557-561.
54. Horbelt D, Delmore J, Meisel R, et al. Mixed germ cell malignancy of the ovary concurrent with pregnancy. Obstet Gynecol. 1994;84:662-664.
55. Karimi ZM, Behtash N, Modares GM. Good pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for ovarian immature teratoma: a case report and literature review. Arch Gynecol Obstet. 2008;277:75-78.
56. Kim DS, Park MI. Maternal and fetal survival following surgery and chemotherapy of endodermal sinus tumor of the ovary during pregnancy: a case report. Obstet Gynecol. 1989;73:503-507.
57. Kim JH, Kim HS, Sung CW, et al. Docetaxel, gemcitabine, and cisplatin administered for non-small cell lung cancer during the first and second trimester of an unrecognized pregnancy. Lung Cancer. 2008;59:270-273.
58. Machado F, Vegas C, Leon J, et al. Ovarian cancer during pregnancy: analysis of 15 cases. Gynecol Oncol. 2007;105:446-450.
59. Malhotra N, Sood M. Endodermal sinus tumor in pregnancy. Gynecol Oncol. 2000;78:265-266.
60. Otton G, Higgins S, Phillips KA, et al. A case of early-stage epithelial ovarian cancer in pregnancy. Int J Gynecol Cancer. 2001;11:413-417.
61. Palaia I, Pernice M, Graziano M, et al. Neoadjuvant chemotherapy plus radical surgery in locally advanced cervical cancer during pregnancy: a case report. Am J Obstet Gynecol. 2007;197:e5-e6.
62. Raffles A, Williams J, Costeloe K, et al. Transplacental effects of maternal cancer chemotherapy. Case report. Br J Obstet Gynaecol. 1989;96:1099-1100.
63. Robova H, Rob L, Hrehorcak M, et al. Endodermal sinus tumor diagnosed in pregnancy: a case report. Int J Gynecol Cancer. 2007;17:914-916.
64. Sood AK, Shahin MS, Sorosky JI. Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy. Gynecol Oncol. 2001;83:599-600.
65. Henderson CE, Elia G, Garfinkel D, et al. Platinum chemotherapy during pregnancy for serous cystadenocarcinoma of the ovary. Gynecol Oncol. 1993;49:92-94.
66. Hubalek M, Smekal-Schindelwig C, Zeimet AG, et al. Chemotherapeutic treatment of a pregnant patient with ovarian dysgerminoma. Arch Gynecol Obstet. 2007;276:179-183.
67. Mendez LE, Mueller A, Salom E, et al. Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer. Obstet Gynecol. 2003;102:1200-1202.
68. Modares GM, Karimi ZM, Behtash N, et al. Preservation of pregnancy in a patient with advanced ovarian cancer at 20 weeks of gestation: case report and literature review. Int J Gynecol Cancer. 2007;17:1140-1143.
69. Picone O, Lhomme C, Tournaire M, et al. Preservation of pregnancy in a patient with a stage IIIB ovarian epithelial carcinoma diagnosed at 22 weeks of gestation and treated with initial chemotherapy: case report and literature review. Gynecol Oncol. 2004;94:600-604.
70. Tabata T, Nishiura K, Tanida K, et al. Carboplatin chemotherapy in a pregnant patient with undifferentiated ovarian carcinoma: case report and review of the literature. Int J Gynecol Cancer. 2008;18:181-184.
71. duBois A, Quinn M, Thigpen T, et al. 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol. 2005;16:viii-Yviii12.
72. Bader AA, Schlembach D, Tamussino KF, et al. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol. 2007;8:79-81.
73. Gadducci A, Cosio S, Fanucchi A, et al. Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature. Anticancer Res. 2003;23:5225-5229.
74. Gonzalez-Angulo AM, Walters RS, Carpenter RJ Jr, et al. Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer. Clin Breast Cancer. 2004;5:317-319.
75. Lycette JL, Dul CL, Munar M, et al. Effect of pregnancy on the pharmacokinetics of paclitaxel: a case report. Clin Breast Cancer. 2006;7:342-344.
76. Mantovani G, Gramignano G, Mais V, et al. Use of chemotherapy for ovarian cancer during human pregnancy: case report and literature review. Eur J Obstet Gynecol Reprod Biol. 2007;131:238-239.
77. Garcia-Manero M, Royo MP, Espinos J, et al. Pregnancy associated breast cancer. Eur J Surg Oncol. 2009;35:215-2118.
78. De Santis M, Lucchese A, De Carolis S, et al. Metastatic breast cancer in pregnancy: first case of chemotherapy with docetaxel. Eur J Cancer Care. 2000;9:235-237.
79. Gainford MC, Clemons M. Breast cancer in pregnancy: are taxanes safe? Clin Oncol. 2006;18:159.
80. Nieto Y, Santisteban M, Aramendia JM, et al. Docetaxel administered during pregnancy for inflammatory breast carcinoma. Clin Breast Cancer. 2006;6:533-534.
81. Potluri V, Lewis D, Burton GV. Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of the literature. Clin Breast Cancer. 2006;7:167-170.
82. Sekar R, Stone PR. Trastuzumab use for metastatic breast cancer in pregnancy. Obstet Gynecol. 2007;110:507-510.
83. McNeish IA, Kanfer EJ, Haynes R, et al. Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours. Br J Cancer. 2004;90:1169-1175.
84. Mead GM, Cullen MH, Huddart R, et al. A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial. Br J Cancer. 2005;93:178-184.
85. Cuvier C, Espie M, Extra JM, et al. Vinorelbine in pregnancy. Eur J Cancer. 1997;33:168-169.
86. Giacalone PL, Laffargue F, Benos P. Chemotherapy for breast carcinoma during pregnancy: a French national survey. Cancer. 1999;86:2266-2272.
87. Caubel P, Giovangrandi Y, Lasry S, et al. Ovarian seminoma and pregnancy. Apropos of a new case. J Gynecol Obstet Biol Reprod. 1989;18:487-491.
88. Christman JE, Teng NN, Lebovic GS, et al. Delivery of a normal infant following cisplatin, vinblastine, and bleomycin (PVB) chemotherapy for malignant teratoma of the ovary during pregnancy. Gynecol Oncol. 1990;37:292-295.
89. Malone JM, Gershenson DM, Creasy RK, et al. Endodermal sinus tumor of the ovary associated with pregnancy. Obstet Gynecol. 1986;68:86S-89S.
90. Motegi M, Takakura S, Takano H, et al. Adjuvant chemotherapy in a pregnant woman with endodermal sinus tumor of the ovary. Obstet Gynecol. 2007;109:537-540.
91. Gralla RJ, Osoba D, Kris MG, et al. Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. J Clin Oncol. 1999;17: 2971-2994.
92. Blanford AT, Murphy BE. In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta. Am J Obstet Gynecol. 1977;127:264Y267.
93. Aghajafari F, Murphy K, Matthews S, et al. Repeated doses of antenatal corticosteroids in animals: a systematic review. Am J Obstet Gynecol. 2002;186:843-849.
94. de Vries A, Holmes MC, Heijnis A, et al. Prenatal dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic-pituitary-adrenal axis function. J Clin Invest. 2007;117:1058-1067.
95. Antenatal corticosteroids revisited: repeat courses-National Institutes of Health Consensus Development Conference Statement, August 17-18, 2000. Obstet Gynecol. 2001;98:144-150.
96. Crowther CA, Doyle LW, Haslam RR, et al. Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. N Engl J Med. 2007;357:1179-1189.
97. Wapner RJ, Sorokin Y, Mele L, et al. Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med. 2007;357: 1190-1198.
98. Ozer H, Armitage JO, Bennett CL, et al. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol. 2000;18:3558-3585.
99. MacDougall MK, LeGrand SB, Walsh D. Symptom control in the pregnant cancer patient. Semin Oncol. 2000;27:704-711.
100. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. Philadelphia, PA. Lippincott Williams & Wilkins; 2008.
101. Siu SS, Yip SK, Cheung CW, et al. Treatment of intractable hyperemesis gravidarum by ondansetron. Eur J Obstet Gynecol Reprod Biol. 2002;105:73-74.
102. Wood NS, Marlow N, Costeloe K, et al. Neurologic and developmental disability after extremely preterm birth. EPICure Study Group. N Engl J Med. 2000;343:378-384.
103. Doyle LW. Neonatal intensive care at borderline viabilityVis it worth it? Early Hum Dev. 2004;80:103-113.
104. Mikkola K, Ritari N, Tommiska V, et al. Neurodevelopmental outcome at 5 years of age of a national cohort of extremely low birth weight infants who were born in 1996-1997. Pediatrics. 2005;116: 1391-1400.
105. Ancel PY, Livinec F, Larroque B, et al. Cerebral palsy among very preterm children in relation to gestational age and neonatal ultrasound abnormalities: the EPIPAGE cohort study. Pediatrics. 2006;117:828-835.
106. Crowley P, Chalmers I, Keirse MJ. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol. 1990;97:11-25.
107. Alexander A, Harris RM, Grossman D, et al. Vulvar melanoma: diffuse melanosis and metastasis to the placenta. J Am Acad Dermatol. 2004;50:293-298.
108. Cailliez D, Moirot MH, Fessard C, et al. Placental localisation of cancer of the cervix. J Gynecol Obstet Biol Reprod. 1980; 9:461-463.
109. Chelghoum Y, Vey N, Raffoux E, et al. Acute leukemia during pregnancy: a report on 37 patients and a review of the literature. Cancer. 2005;104:110-117.
110. Ring AE, Smith IE, Jones A, et al. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol. 2005;23:4192-4197.
111. Hahn KM, Johnson PH, Gordon N, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006;107:1219-1226.
112. Van Calsteren K, Berteloot P, Hanssens M, et al. In utero exposure to chemotherapy: effect on cardiac and neurologic outcome. J Clin Oncol. 2006;24:e16-e17.
113. Meyer-Wittkopf M, Barth H, Emons G, et al. Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature. Ultrasound Obstet Gynecol. 2001;18:62-66.
114. Aviles A, Neri N, Nambo MJ. Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy. Ann Oncol. 2006;17:286-288.
115. Yahata T, Numata M, Kashima K, et al. Conservative treatment of stage IA1 adenocarcinoma of the cervix during pregnancy. Gynecol Oncol. 2008;109:49-52.
116. Hertel H, Possover M, Kuhne-Heid R, et al. Laparoscopic lymph node staging of cervical cancer in the 19th week of pregnancy. A case report. Surg Endosc. 2001;15:324.
117. Alouini S, Rida K, Mathevet P. Cervical cancer complicating pregnancy: implications of laparoscopic lymphadenectomy. Gynecol Oncol. 2008;108:472-477.
118. Covell LM, Disciullo AJ, Knapp RC. Decidual change in pelvic lymph nodes in the presence of cervical squamous cell carcinoma during pregnancy. Am J Obstet Gynecol. 1977;127:674-676.
119. Ashraf M, Boyd CB, Beresford WA. Ectopic decidual cell reaction in para-aortic and pelvic lymph nodes in the presence of cervical squamous cell carcinoma during pregnancy. J Surg Oncol. 1984;26:6-8.
120. Burnett RA, Millan D. Decidual change in pelvic lymph nodes: a source of possible diagnostic error. Histopathology. 1986;10:1089-1092.
121. Cobb CJ. Ectopic decidua and metastatic squamous carcinoma: presentation in a single pelvic lymph node. J Surg Oncol. 1988;38:126-129.
122. Hogg R, Ungar L, Hazslinszky P. Radical hysterectomy for cervical carcinoma in pregnant women-a case of decidua mimicking metastatic carcinoma in pelvic lymph nodes. Eur J Gynaecol Oncol. 2005;26:499-500.
123. Giacalone PL, Laffargue F, Benos P, et al. Cis-platinum neoadjuvant chemotherapy in a pregnant woman with invasive carcinoma of the uterine cervix. Br J Obstet Gynaecol. 1996;103:932-934.
124. Tewari K, Cappuccini F, Gambino A, et al. Neoadjuvant chemotherapy in the treatment of locally advanced cervical carcinoma in pregnancy: a report of two cases and review of issues specific to the management of cervical carcinoma in pregnancy including planned delay of therapy. Cancer. 1998;82:1529-1534.
125. Marana HR, de Andrade JM, Silva Mathes AC, et al. Chemotherapy in the treatment of locally advanced cervical cancer and pregnancy. Gynecol Oncol. 2001;80:272-274.
126. Bader AA, Petru E, Winter R. Long-term follow-up after neoadjuvant chemotherapy for high-risk cervical cancer during pregnancy. Gynecol Oncol. 2007;105:269-272.
127. Karam A, Feldman N, Holschneider CH. Neoadjuvant cisplatin and radical cesarean hysterectomy for cervical cancer in pregnancy. Nat Clin Pract Oncol. 2007;4:375-380.
128. Robova H, Pluta M, Hrehorcak M, et al. High-dose density chemotherapy followed by simple trachelectomy: full-term pregnancy. Int J Gynecol Cancer. 2008;18:1367-1371.
129. Benhaim Y, Pautier P, Bensaid C, et al. Neoadjuvant chemotherapy for advanced stage cervical cancer in a pregnant patient: report of one case with rapid tumor progression. Eur J Obstet Gynecol Reprod Biol. 2008;136:267-268.
130. Benedetti PP, Bellati F, Pastore M, et al. An update in neoadjuvant chemotherapy in cervical cancer. Gynecol Oncol. 2007;107:S20-S22.
131. Mori T, Hosokawa K, Kinoshita Y, et al. Neoadjuvant chemotherapy with weekly carboplatin and paclitaxel for locally advanced cervical carcinoma. Int J Gynecol Cancer. 2008;18:85-89.
132. Moore KN, Herzog TJ, Lewin S, et al. A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer. Gynecol Oncol. 2007;105:299-303.
133. Ungar L, Smith JR, Palfalvi L, et al. Abdominal radical trachelectomy during pregnancy to preserve pregnancy and fertility. Obstet Gynecol. 2006;108:811-814.
134. van de Nieuwenhof HP, van Ham MA, Lotgering FK, et al. First case of vaginal radical trachelectomy in a pregnant patient. Int J Gynecol Cancer. 2008;18:1381-1385.
135. Gordon AN, Jensen R, Jones HW III. Squamous carcinoma of the cervix complicating pregnancy: recurrence in episiotomy after vaginal delivery. Obstet Gynecol. 1989;73:850-852.
136. Khalil AM, Khatib RA, Mufarrij AA, et al. Squamous cell carcinoma of the cervix implanting in the episiotomy site. Gynecol Oncol. 1993;51:408-410.
137. Cliby WA, Dodson MK, Podratz KC. Cervical cancer complicated by pregnancy: episiotomy site recurrences following vaginal delivery. Obstet Gynecol. 1994;84:179-182.
138. Van den Broek NR, Lopes AD, Ansink A, et al. BMicroinvasive[ adenocarcinoma of the cervix implanting in an episiotomy scar. Gynecol Oncol. 1995;59:297-299.
139. Goldman NA, Goldberg GL. Late recurrence of squamous cell cervical cancer in an episiotomy site after vaginal delivery. Obstet Gynecol. 2003;101:1127-1129.
140. Heron DE, Axtel A, Gerszten K, et al. Villoglandular adenocarcinoma of the cervix recurrent in an episiotomy scar: a case report in a 32-year-old female. Int J Gynecol Cancer. 2005;15:366-371.
141. Baloglu A, Uysal D, Aslan N, et al. Advanced stage of cervical carcinoma undiagnosed during antenatal period in term pregnancy and concomitant metastasis on episiotomy scar during delivery: a case report and review of the literature. Int J Gynecol Cancer. 2007;17:1155-1159.
142. Neumann G, Rasmussen KL, Petersen LK. Cervical adenosquamous carcinoma: tumor implantation in an episiotomy scar. Obstet Gynecol. 2007;110:467-469.
143. Sivanesaratnam V, Jayalakshmi P, Loo C. Surgical management of early invasive cancer of the cervix associated with pregnancy. Gynecol Oncol. 1993;48:68-75.
144. Method MW, Brost BC. Management of cervical cancer in pregnancy. Semin Surg Oncol. 1999;16:251-260.
145. Gitsch G, van Eijkeren M, Hacker NF. Surgical therapy of vulvar cancer in pregnancy. Gynecol Oncol. 1995;56:312-315.
146. Couvreux-Dif D, Lhomme C, Querleu D, et al. Cancer of the vulva and pregnancy: two cases and review of the literature. J Gynecol Obstet Biol Reprod. 2003;32:46-50.
147. Ogunleye D, Lewin SN, Huettner P, et al. Recurrent vulvar carcinoma in pregnancy. Gynecol Oncol. 2004;95:400-401.
148. Alexander A, Samlowski WE, Grossman D, et al. Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. J Clin Oncol. 2003;21:2179-2186.
149. Takeuchi T, Suzuki S, Hayashi Z, et al. Primary ovarian tumor undergoing surgical management during pregnancy. J Nippon Med Sch. 2002;69:39-42.
150. Patterson DM, Murugaesu N, Holden L, et al. A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites. Int J Gynecol Cancer. 2008;18:43-50.
151. Tewari K, Brewer C, Cappuccini F, et al. Advanced-stage small cell carcinoma of the ovary in pregnancy: long-term survival after surgical debulking and multiagent chemotherapy. Gynecol Oncol. 1997;66:531-534.
152. Zhao XY, Huang HF, Lian LJ, et al. Ovarian cancer in pregnancy: a clinicopathologic analysis of 22 cases and review of the literature. Int J Gynecol Cancer. 2006;16:8-15.
153. Ishioka S, Hayashi T, Endo T, et al. Advanced epithelial ovarian carcinoma during pregnancy. Int J Clin Oncol. 2007; 12:375-378.
154. Behtash N, Karimi ZM, Modares GM, et al. Ovarian carcinoma associated with pregnancy: a clinicopathologic analysis of 23 cases and review of the literature. BMC Pregnancy Childbirth. 2008;8:3.
155. Malfetano JH, Goldkrand JW. Cis-platinum combination chemotherapy during pregnancy for advanced epithelial ovarian carcinoma. Obstet Gynecol. 1990;75:545-547.
156. Schover LR. Psychosocial issues associated with cancer in pregnancy. Semin Oncol. 2000;27:699-703.
157. Ibrahim EM, Ezzat AA, Baloush A, et al. Pregnancy-associated breast cancer: a case-control study in a young population with a high-fertility rate. Med Oncol. 2000;17:293-300.
158. Zemlickis D, Lishner M, Degendorfer P, et al. Maternal and fetal outcome after invasive cervical cancer in pregnancy. J Clin Oncol. 1991;9:1956-1961.